Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

566 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC.
Saw SPL, Low YF, Lai GGY, Chan LL, Wong WKY, Tsui G, Chen OH, Seet AOL, Tan WC, Tan AC, Chan JWK, Teh YL, Tan WL, Ng QS, Ang MK, Kanesvaran R, Lim DWT, Tan DSW, Mok TSK, Li MSC. Saw SPL, et al. Among authors: chan jwk, chan ll. Lung Cancer. 2024 Jul;193:107856. doi: 10.1016/j.lungcan.2024.107856. Epub 2024 Jun 15. Lung Cancer. 2024. PMID: 38889498 Free article.
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma.
Chan SL, Cheng PNM, Liu AM, Chan LL, Li L, Chu CM, Chong CCN, Lau YM, Yeo W, Ng KKC, Yu SCH, Mok TSK, Chan AWH. Chan SL, et al. Among authors: chan ll, chan awh. Invest New Drugs. 2021 Oct;39(5):1375-1382. doi: 10.1007/s10637-021-01111-8. Epub 2021 Apr 15. Invest New Drugs. 2021. PMID: 33856599 Free PMC article. Clinical Trial.
Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease.
Li MSC, Lee KWC, Mok KKS, Loong HHF, Lam KC, Mok FST, Chan LL, Lau YM, Chan KP, Ng JTY, Wong WKY, Lam BHW, Chen ACC, Lee MMP, Chen OH, Mok TSK. Li MSC, et al. Among authors: chan ll, chan kp. JTO Clin Res Rep. 2024 Feb 10;5(4):100648. doi: 10.1016/j.jtocrr.2024.100648. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38590729 Free PMC article.
Next-generation immunotherapy: igniting new hope for lung cancer.
Li MSC, Chan ALS, Mok KKS, Chan LL, Mok TSK. Li MSC, et al. Among authors: chan ll. Ther Adv Med Oncol. 2024 Dec 7;16:17588359241302021. doi: 10.1177/17588359241302021. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39649017 Free PMC article. Review.
566 results